Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders

NCT06661252 is registered in ClinicalTrials.gov with Diag-Nose Medical Pty Ltd as lead sponsor.

NCT NCT06661252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06661252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders
Lead sponsor
Diag-Nose Medical Pty Ltd
Phase
Observational
Overall status
Completed
Start date
January 8, 2025
Completion date
November 25, 2025
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma and rhinitis, asthma patients, asthma, chronic obstructive pulmonary disease (copd), asthmatic patients, chronic obstructive pulmonary disease (copd), chronic sinusitis with or without nasal polyps, healthy volunteers, non-allergic rhinitis, rhinitis allergic, rhinitis, allergic, perennial and/or seasonal